Hengeler Mueller advises Schön Klinik on equity investment by an investor
05. July 2016
Schön Klinik SE, one of the leading clinic operators in Germany, agreed with a financial partner to become a minority shareholder in the company. With this decision, Schön Klinik confirms its ambitions to continue its sustainable and profitable growth. The management under the leadership of Dieter Schön, managing director and CEO, remains unchanged. Details on the purchase price and the size of the shareholding were not disclosed. Upon receiving the necessary antitrust approvals, the transaction is expected to be closed in fall 2016.
Hengeler Mueller advises Schön Klinik SE on this transaction. The team includes partners Hans-Jörg Ziegenhain (M&A), Simon Patrick Link (Corporate) (both Munich), Thorsten Mäger (Antitrust, Düsseldorf), Markus Röhrig (Antitrust, Brussels), Matthias Scheifele (Tax, Frankfurt), Dirk Uwer (Regulation, Düsseldorf), counsel Patrick H. Wilkening (IT/IP, Düsseldorf) as well as associates Philipp Dornbach, Daniel Illhardt (both M&A), Elisabeth Kreuzer (Corporate) (all Munich), Martin Mohr (Tax, Frankfurt), Matthias Rothkopf (Antitrust), Deniz Tschammler (Regulation) (both Düsseldorf), Peter Wehner (Employment, Frankfurt), Christoph Wilken (Antitrust, Düsseldorf).